Evidence map›Paper›PMID 24031164›Full record

ArticleCurrent opinion in colloid & interface science2013

Model cell membranes: Techniques to form complex biomimetic supported lipid bilayers via vesicle fusion.

Gregory J Hardy, Rahul Nayak, Stefan Zauscher

Abstract read
In one paragraph

Article in Current opinion in colloid & interface science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 232 citations in OpenAlex.

  1. Review
  2. Article
  3. Synergistic Membrane Disruption ofBiomimetics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Binding ofLangmuir : the ACS journal of surfaces and colloids · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gregory J HardyDepartment of Mechanical Engineering and Materials Science, Duke University, 144 Hudson Hall Box 90300, Durham, NC 27708, USA. ; Tel: +1 (919) 660-5360.
Rahul Nayak
Stefan Zauscher
Duke University · US

Funding

Structural Biology and Biphysics Training ProgramT32GM008487 · NIGMS · DUKE UNIVERSITY · PI OAS, TERRENCE GILBERT · 1994 to 2014
$2.9M
HIV-1 Neutralizing Antibody Binding to Viral Membrane MimicsR21AI102814 · NIAID · DUKE UNIVERSITY · PI ZAUSCHER, STEFAN · 2012 to 2013
$407k
NIAID NIH HHS R21 AI102814
6 · The paper itself

Abstract

Vesicle fusion has long provided an easy and reliable method to form supported lipid bilayers (SLBs) from simple, zwitterionic vesicles on siliceous substrates. However, for complex compositions, such as vesicles with high cholesterol content and multiple lipid types, the energy barrier for the vesicle-to-bilayer transition is increased or the required vesicle-vesicle and vesicle-substrate interactions are insufficient for vesicle fusion. Thus, for vesicle compositions that more accurately mimic native membranes, vesicle fusion often fails to form SLBs. In this paper, we review three approaches to overcome these barriers to form complex, biomimetic SLBs via vesicle fusion: (i) optimization of experimental conditions (e.g., temperature, buffer ionic strength, osmotic stress, cation valency, and buffer pH), (ii) α-helical (AH) peptide-induced vesicle fusion, and (iii) bilayer edge-induced vesicle fusion. AH peptide-induced vesicle fusion can form complex SLBs on multiple substrate types without the use of additional equipment. Bilayer edge-induced vesicle fusion uses microfluidics to form SLBs from vesicles with complex composition, including vesicles derived from native cell membranes. Collectively, this review introduces vesicle fusion techniques that can be generalized for many biomimetic vesicle compositions and many substrate types, and thus will aid efforts to reliably create complex SLB platforms on a range of substrates.

Identifiers

PMID24031164
PMCPMC3767439
OpenAlexW2067526822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.